About this episode

The episode discusses the upcoming reports from major tech companies, the trial between Elon Musk and Sam Altman, and advancements in cardiac drug research.

With five of the Mag 7 reporting this week, we discuss whether investors should temper their capex expectations. The trial between Elon Musk and Sam Altman kicks off. Plus, the potential next frontier in preventing heart attacks.

More episodes of The Exchange

• DOJ Drops Powell Probe, Big Tech on Deck, and Intel's Gain, AMD's...Gain? 4/24/26 · April 24, 2026 · 44 min
• Debunking Oil Myths, the New Gamestop?, and Saving Spirit 4/23/26 · April 23, 2026 · 44 min
• Tech Still Cheap, SpaceX's $60B Deal, and Google's Enterprise Fight 4/22/26 · April 22, 2026 · 44 min
• Apple's Turnover, Warsh Gets Grilled, and Airline Indigestion 4/21/26 · April 21, 2026 · 44 min
• The Exchange 4/20/26 · April 20, 2026 · 44 min
• Markets Rally, Airlines Soar, and Oracle Bounces Back 4/17/26 · April 17, 2026 · 48 min

Explore listener stats, chart rankings, contacts and more on the The Exchange podcast page.